Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int J Hematol ; 98(2): 250-7, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23846384

RESUMO

A 65-year-old man was diagnosed with angioimmunoblastic T-cell lymphoma (AITL) with bone marrow (BM) infiltration and myelofibrosis (MF). The BM infiltration and the condition of the MF improved following CHOP therapy (cyclophosphamide hydrate, doxorubicin hydrochloride, vincristine sulfate, and prednisolone). After complete remission was achieved, early central nervous system recurrence was noted, with no evidence of BM infiltration or MF. The lymph nodes and BM were examined for cytokines by immunohistochemical staining with monoclonal murine antibodies. The lymphoma cells were positive only for platelet-derived growth factor (PDGF) and negative for basic fibroblast growth factor, fibronectin, vascular endothelial growth factor, transforming growth factor-ß (TGF-ß), tumor necrosis factor α, interleukin-1ß, and interleukin-6. It was thus inferred that the lymphoma cells producing PDGF caused the MF, and that the absence of MF at relapse may have been attributable to the absence of BM infiltration. There have been seven reported cases of AITL with intercurrent MF, although cytokine data (elevations of blood PDGF and TGFß levels) are available for only one case. The present report is to our knowledge the only report of a case of AITL complicated by MF for which the results of immunohistostaining with anticytokine antibodies are available.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem , Linfoma de Células T , Proteínas de Neoplasias/biossíntese , Fator de Crescimento Derivado de Plaquetas/biossíntese , Mielofibrose Primária , Idoso , Medula Óssea/metabolismo , Medula Óssea/patologia , Ciclofosfamida/administração & dosagem , Citocinas/metabolismo , Doxorrubicina/administração & dosagem , Humanos , Linfonodos/metabolismo , Linfonodos/patologia , Linfoma de Células T/tratamento farmacológico , Linfoma de Células T/metabolismo , Linfoma de Células T/patologia , Masculino , Prednisona/administração & dosagem , Mielofibrose Primária/tratamento farmacológico , Mielofibrose Primária/metabolismo , Mielofibrose Primária/patologia , Vincristina/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...